Stock Events

Stock Events

Mineralys Therapeutics (MLYS) Q4 2022 Earnings

10FebExpected

Q4 2022

-1.74

-1.73

-1.73

-1.72

Details

Expected EPS

-1.72

Actual EPS

-1.74

Surprise EPS

-0.02

Surprise Percent

+1.16%

Description

Mineralys Therapeutics (MLYS) has reported earnings of -1.74 per share for Q4 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.